Connect Biopharma Holdings Limited - Ordinary Shares (CNTB) earnings
CNTB earnings moved a median of +5.15% by the close. Quarterly and annual CNTB reports and results, each read against the price at its own news timestamp. Back to the CNTB overview →
12 measured CNTB earnings events.
Where these CNTB earnings landedvs 12 measured CNTB earnings reactions
| Middle 50% of CNTB earnings reactions | -4.44% to +9.01% |
|---|---|
| Median reaction (to close) | +5.15% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 CNTB earnings events with a measured close landed between -4.44% and +9.01%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +2.15% | +9.01% | |
| Form 10-Q Connect Biopharma Holdin For: Jun 30 | SEC filing · Form 10-Q | +2.15% | +9.01% | |
| Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | +0.00% | +12.61% | |
| Form 10-Q Connect Biopharma Holdin For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +12.61% | |
| Form 10-K Connect Biopharma Holdin For: Dec 31 | SEC filing · Form 10-K | -2.63% | +2.26% | |
| Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +5.37% | +8.05% | |
| Form 10-Q Connect Biopharma Holdin For: Sep 30 | SEC filing · Form 10-Q | +5.37% | +8.05% | |
| Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -5.69% | -4.07% | |
| Form 10-Q Connect Biopharma Holdin For: Jun 30 | SEC filing · Form 10-Q | -5.69% | -4.07% | |
| Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -0.61% | -5.58% | |
| Form 10-Q Connect Biopharma Holdin For: Mar 31 | SEC filing · Form 10-Q | -0.61% | -5.58% | |
| Form 10-K Connect Biopharma Holdin For: Dec 31 | SEC filing · Form 10-K | +0.00% | -19.12% |
Keep exploring
More CNTB: analyst actions → · SEC filings → · CNTB overview →